[Severe bleeding in a case of factor VIII inhibitor associated with intravascular lymphomatosis].
A 70-year-old man was admitted to Jichi Medical School Hospital on October 1, 1990, complaining of spontaneous severe hemorrhage in his extremities. He had prolonged APTT value and normal PT value. Factor VIII level was markedly diminished, and a high titer of factor VIII inhibitor was observed. He was diagnosed as having idiopathic factor VIII inhibitor because of no sign of underlying disorders. He received prednisolone and immunosuppressants, subsequently with plasma exchange and bolous factor VIII, resulting in disappearance of the inhibitor. He was admitted again in February 1991, because of the reappearance of factor VIII inhibitor. In June, furthermore, bone marrow smears showed infiltration of atypical B cells, although no evidence of organomegaly and adenopathy was observed. Therefore, he was suspected to have primary bone marrow lymphoma. He received CHOP therapy, but he died of multiorgan failure. Postmortem autopsy demonstrated multifocal intravascular lymphomatosis with marked intravascular involvement of the lung, liver, kidney, adrenal glands, spleen and bone marrow. Lymph nodes were not swollen, showing little evidence of intravascular lymphomatosis.
Ohtaka
A
A
Department of Medicine, Jichi Medical School.
Muroi
K
K
Izumi
T
T
Suzuki
T
T
Hoshino
M
M
Miwa
A
A
Sakata
Y
Y
Sakamoto
S
S
Miura
Y
Y
Shinohara
N
N
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005169:Factor VIII / Q000037:antagonists & inhibitors*; D006390:Hemangioendothelioma / Q000097:blood / Q000473:pathology*; D006470:Hemorrhage / Q000209:etiology*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000097:blood / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D012871:Skin Diseases / Q000209:etiology*; D012878:Skin Neoplasms / Q000473:pathology*; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D005169:Factor VIII; D011241:Prednisone